CT

Cancer Treatment Reviews

Cancer Treatment Reviews is an international journal that provides state of the art, authoritative review articles to the clinician and researcher to keep them abreast of modern concepts and the latest developments in cancer treatment research.

Looking to publish in Cancer Treatment Reviews? Livewrite integrates seamlessly with Word to help you write, edit, and format faster.

Try Livewrite Now
Subject Oncology
Impact Factor 10.5
Quartile Q1
Open Access Type Hybrid
ISSN 0305-7372
eISSN 1532-1967
Invitation Only No
Cost Range Article publishing charge applies for open access articles; amount not specified.

Submission Instructions

Cancer Treatment Reviews accepts the following article types. Click on an article type to view submission instructions.

Tumour Review

Cover Letter Cover Letter requirements are not specified.
Abstract Abstract must not exceed 250 words.
Manuscript Manuscript must not exceed 5000 words, excluding tables and figures. Manuscript must be divided into clearly defined sections using headings. Submission must include 1 to 7 keywords in English and article highlights provided as a separate editable file containing 3 to 5 bullet points of no more than 85 characters each, and images created or altered using generative AI or AI-assisted tools are not permitted.
References A maximum of 100 references is recommended, with exceptions subject to editorial approval. References must use a numbered square-bracket citation style. Reference list must be numbered in the order of first appearance in the text, journal names must be abbreviated according to the List of Title Word Abbreviations, and references with more than 6 authors must list the first 6 followed by 'et al.'.
Figures & Tables Manuscript is limited to 6 figures and/or tables. Figures must be uploaded as separate files, while tables must be submitted as editable text. All figures and tables must be cited in the text, numbered consecutively in order of appearance, and accompanied by captions.
Reformat to Cancer Treatment Reviews using Livewrite Premium

Systematic Or Meta-Analysis Studies

Cover Letter Cover Letter requirements are not specified.
Abstract Abstract must not exceed 250 words.
Manuscript Manuscript must not exceed 5000 words excluding tables and figures. Manuscript must be divided into clearly defined sections using headings. Submission must include 1 to 7 English keywords and article highlights provided as a separate editable file containing 3 to 5 bullet points of no more than 85 characters each.
References A maximum of 100 references is recommended, with exceptions subject to editorial approval. References must be cited by number in square brackets. Reference list must be numbered in the order of appearance in the text, include the required bibliographic details, use abbreviated journal names, and list the first 6 authors followed by 'et al.' when there are more than 6 authors.
Figures & Tables A maximum of 6 figures and/or tables is allowed. Figures must be uploaded as separate files, while tables must be submitted as editable text. All figures and tables must be cited in the text, numbered consecutively, and provided with captions.
Reformat to Cancer Treatment Reviews using Livewrite Premium

Recent Publications

Integrin beta-6: Its emerging role as a therapeutic target in solid tumors

Rachel E. Sanborn, Solange Peters, David Barbie

10.1016/j.ctrv.2026.103128
View Publication

Multigene assays in early breast cancer: Current evidence, limits and future directions

Emanuela Fina, Vincenzo Di Lauro, Alessandro Rizzo, Samantha Bove, Maria Colomba Comes, Michele De Laurentiis, Raffaella Massafra

10.1016/j.ctrv.2026.103136
View Publication

Interleukin-8: a tumor-agnostic biomarker integrating cancer biology and host response across solid tumors

Ilaria Mariangela Scaglione, Chiara Bazzichetto, Michele Borghesani, Francesca Zacchi, Serena Eccher, Marco Sposito, Jessica Insolda, Elena Giontella, Elena Trevisani, Alice Avancini, Daniela Tregnago, Sara Cingarlini, Sara Pilotto, Fabiana Conciatori, Lorenzo Belluomini, Michele Milella

10.1016/j.ctrv.2026.103135
View Publication

Perioperative strategies for resectable EGFR-Mutant NSCLC: evidence hierarchy and clinical decision-making

Shengliang Zhao, Xiaoqing Liu, Jingsi Wang, Bo Tang, Qin Long, Xingwei Tang, Jigang Dai, Yingjiu Jiang, Quanxing Liu

10.1016/j.ctrv.2026.103138
View Publication

Expanding the therapeutic Frontier: Liver transplantation for unresectable colorectal liver metastases

Alex B. Munster, Umair Mahmood, Heather Fuller, Hajun Seo, Jamie Murphy, Krishna Menon, Charles Imber, Chetan Bhan, Khurum Khan

10.1016/j.ctrv.2026.103139
View Publication

Frequently asked questions

How long does it take to publish?

Median 4 days from submission to first decision.

Reformat to Cancer Treatment Reviews using Livewrite Premium

What are the publication costs?

Article publishing charge applies for open access articles; amount not specified.

Reformat to Cancer Treatment Reviews using Livewrite Premium

Research Topics

Cancer Treatment and Pharmacology Human auditory perception and evaluation Diverse Scientific and Economic Studies Lung Cancer Treatments and Mutations HER2/EGFR in Cancer Research Educational Robotics and Engineering Breast Cancer Treatment Studies Lung Cancer Research Studies Cancer Immunotherapy and Biomarkers Colorectal Cancer Treatments and Studies Cancer Genomics and Diagnostics Bone health and treatments Neuroendocrine Tumor Research Advances Cancer therapeutics and mechanisms Lymphoma Diagnosis and Treatment Prostate Cancer Treatment and Research Pancreatic and Hepatic Oncology Research Estrogen and related hormone effects Radiopharmaceutical Chemistry and Applications Immunotherapy and Immune Responses CAR-T cell therapy research Advanced Breast Cancer Therapies Ovarian cancer diagnosis and treatment Renal cell carcinoma treatment Chronic Lymphocytic Leukemia Research

Related Journals

LD
Lancet Diabetes & Endocrinology Elsevier BV
MC
Mayo Clinic Proceedings Elsevier BV
JO
Journal Of Ginseng Research Elsevier BV
DM
Diagnostic Microbiology And Infectious Disease Elsevier BV
AO
Annals Of Oncology Elsevier BV
LG
Lancet Gastroenterology & Hepatology Elsevier BV